Skip to main content
Samir Kahwash, MD, Pathology, Columbus, OH, Nationwide Children's Hospital

SamirKahwashMD

Pathology Columbus, OH

Hematopathology, Anatomic Pathology, Clinical Pathology, Pediatric Pathology

Director of Hematology Lab Services Director, Pediatric Pathology Fellowship Program Vice Chair for Education, PPAC Professor, The Ohio State University

Dr. Kahwash is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kahwash's full profile

Already have an account?

Summary

  • Dr. Samir Kahwash is a hematopathologist in Columbus, OH affiliated with Nationwide Children's Hospital and The Ohio State University. He received his medical degree from Damascus University. He specializes in hematopathology, anatomic pathology, clinical pathology, and pediatric pathology and is experienced in pediatric hematopathology and pediatric clinical and surgical pathology. He is a Professor-Clinical at The Ohio State University.

Education & Training

  • Allegheny Health Network Medical Education Consortium
    Allegheny Health Network Medical Education ConsortiumResidency, Pathology-Anatomic and Clinical, 1986 - 1992
  • Damascus University Faculty of Medicine
    Damascus University Faculty of MedicineClass of 1983

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1992 - 2022
  • PA State Medical License
    PA State Medical License 1987 - 2002
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Pathology Recertification
  • American Board of Pathology Hematology
  • American Board of Pathology Pediatric Pathology

Awards, Honors, & Recognition

  • Educator of the year award Dept of pathology- NCH, 2008

Publications & Presentations

PubMed

Abstracts/Posters

  • Sorafenib in Combination with Standard Chemotherapy for Children with High Allelic Ratio FLT3/ITD+ AML Improves Event-Free Survival and Reduces Relapse Risk: A Report ...
    Samir Kahwash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Authored Content

  • Are We Losing Sight of the 'Big Picture' in Medicine?February 2019

Committees

  • AML committee, Childood Oncology Group 2006 - Present
  • Member, ASCP in service examination CMT 2011 - 2017
  • Editor, @pediatricpathologyimages

Hospital Affiliations